|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-3-30
|
|
pubmed:abstractText |
Despite numerous advances in the management of patients with Alzheimer's disease (AD), the proportion of patients treated according to current recommendations remains unknown.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0035-3787
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
161
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
211-3
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15798520-Aged,
pubmed-meshheading:15798520-Alzheimer Disease,
pubmed-meshheading:15798520-Cholinesterase Inhibitors,
pubmed-meshheading:15798520-Drug Industry,
pubmed-meshheading:15798520-Drug Utilization,
pubmed-meshheading:15798520-Female,
pubmed-meshheading:15798520-France,
pubmed-meshheading:15798520-Humans,
pubmed-meshheading:15798520-Insurance, Health,
pubmed-meshheading:15798520-Male
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
[Acetylcholinesterase inhibitor treatment for Alzheimer's disease: the experience in Picardy].
|
|
pubmed:affiliation |
Service de Neurologie et Laboratoire de Neurosciences et Pathologies (FRE CNRS 2726).
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
